These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36875531)

  • 1. Delphi Panel Consensus Regarding Current Clinical Practice Management Options for
    Farid M; Ayres BD; Donnenfeld E; Gaddie IB; Gupta PK; Holland E; Lindstrom R; Pflugfelder SC; Karpecki PM; Nichols KK; Starr CE; Yeu E
    Clin Ophthalmol; 2023; 17():667-679. PubMed ID: 36875531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH).
    Ayres BD; Donnenfeld E; Farid M; Gaddie IB; Gupta PK; Holland E; Karpecki PM; Lindstrom R; Nichols KK; Pflugfelder SC; Starr CE; Yeu E
    Eye (Lond); 2023 Oct; 37(15):3249-3255. PubMed ID: 36964261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of
    Trattler W; Karpecki P; Rapoport Y; Sadri E; Schachter S; Whitley WO; Yeu E
    Clin Ophthalmol; 2022; 16():1153-1164. PubMed ID: 35449733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collarette Elimination and
    Gonzalez-Salinas R; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):479-484. PubMed ID: 34415795
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial.
    Gonzalez-Salinas R; Karpecki P; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H
    Cont Lens Anterior Eye; 2022 Aug; 45(4):101492. PubMed ID: 34332895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of
    Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H; Gonzalez-Salinas R
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1653-1661. PubMed ID: 35914297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial Impact of
    O'Dell L; Dierker DS; Devries DK; Garlich J; Whitley WO; Holdbrook M; Baba SN; Yeu E
    Clin Ophthalmol; 2022; 16():2979-2987. PubMed ID: 36081601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
    Sadri E; Paauw JD; Ciolino JB; Nijm L; Simmons B; Meyer J; Gaddie IB; Berdy GJ; Holdbrook M; Baba SN; Jalalat P; Yeu E
    Cornea; 2024 Feb; ():. PubMed ID: 38334465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Demodex diagnosis in the clinical setting using a novel in situ technique.
    Muntz A; Purslow C; Wolffsohn JS; Craig JP
    Cont Lens Anterior Eye; 2020 Aug; 43(4):345-349. PubMed ID: 31806355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Demodex: a systematic review of the clinical literature.
    Zhang AC; Muntz A; Wang MTM; Craig JP; Downie LE
    Ophthalmic Physiol Opt; 2020 Jul; 40(4):389-432. PubMed ID: 32691894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea tree oil for Demodex blepharitis.
    Savla K; Le JT; Pucker AD
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013333. PubMed ID: 32589270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demodex Blepharitis: An Analysis of Nine Patients.
    Lee YI; Seo M; Cho KJ
    Korean J Parasitol; 2022 Dec; 60(6):429-432. PubMed ID: 36588421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of
    Gonzalez-Salinas R; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H
    J Ophthalmol; 2021; 2021():3862684. PubMed ID: 34603770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1).
    Yeu E; Wirta DL; Karpecki P; Baba SN; Holdbrook M;
    Cornea; 2023 Apr; 42(4):435-443. PubMed ID: 35965392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-Masked and Unmasked Prospective Study of Terpinen-4-ol Lid Scrubs With Microblepharoexfoliation for the Treatment of Demodex Blepharitis.
    Epstein IJ; Rosenberg E; Stuber R; Choi MB; Donnenfeld ED; Perry HD
    Cornea; 2020 Apr; 39(4):408-416. PubMed ID: 31939919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Eyelid Signs are Suggestive of
    Udomwech L; Phasuk N
    Clin Ophthalmol; 2021; 15():671-678. PubMed ID: 33628010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic role of Demodex mites in blepharitis.
    Liu J; Sheha H; Tseng SC
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):505-10. PubMed ID: 20689407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demodex-related marginal blepharitis in Japan].
    Kawakita T; Kawashima M; Ibrahim O; Murato D; Tsubota K
    Nippon Ganka Gakkai Zasshi; 2010 Dec; 114(12):1025-9. PubMed ID: 21268817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lid hygiene on the tear film and ocular surface, and the prevalence of Demodex blepharitis in university students.
    Murphy O; O' Dwyer V; Lloyd-McKernan A
    Cont Lens Anterior Eye; 2020 Apr; 43(2):159-168. PubMed ID: 31548151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panel.
    Fonseca R; Rossi A; Medhekar R; Voelker J; Homan T; Wilcock J; Karakusevic A; Cochrane J; Bridge D; Perry R; Kaila S; Davies FE
    Future Oncol; 2024 May; ():1-12. PubMed ID: 38861282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.